Get the Stockscreener App
123.75
0.26%
0.315
Natera Inc stock is traded at $123.75, with a volume of 254.77K.
It is up +0.26% in the last 24 hours and down -4.69% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$123.44
Open:
$123.39
24h Volume:
254.77K
Relative Volume:
0.23
Market Cap:
$15.33B
Revenue:
$1.21B
Net Income/Loss:
$-365.46M
P/E Ratio:
-25.68
EPS:
-4.82
Net Cash Flow:
$-186.98M
1W Performance:
-0.79%
1M Performance:
-4.69%
6M Performance:
+27.61%
1Y Performance:
+189.56%
1-Day Range:
$122.08
$124.39
1-Week Range:
$120.67
$127.49
52-Week Range:
$40.61
$133.54
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
How Is The Market Feeling About Natera? - Benzinga
Harbor Capital Advisors Inc. Has $2.30 Million Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
International Assets Investment Management LLC Acquires 14,828 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Learn to Evaluate (NTRA) using the Charts - Stock Traders Daily
Natera, Inc. (NASDAQ:NTRA) CFO Sells $235,955.70 in Stock - MarketBeat
Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTR - GuruFocus.com
Natera CFO Michael Burkes sells $235,955 in stock By Investing.com - Investing.com South Africa
Natera CFO Michael Burkes sells $235,955 in stock - Investing.com India
Natera to Report its Third Quarter 2024 Results on November 12, 2024 - BioSpace
Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds (NTRA) - Seeking Alpha
Natera's president of clinical diagnostics sells $141,379 in shares - Investing.com India
Natera CFO Michael Burkes sells $236,771 in stock By Investing.com - Investing.com Australia
Natera's chief legal officer Daniel Rabinowitz sells $124,948 in shares By Investing.com - Investing.com South Africa
Natera's president of clinical diagnostics sells $141,379 in shares By Investing.com - Investing.com South Africa
Natera CEO Leonard Chapman sells $468,113 in stock By Investing.com - Investing.com South Africa
Natera's chief legal officer Daniel Rabinowitz sells $124,948 in shares - Investing.com India
Natera CFO Michael Burkes sells $236,771 in stock - Investing.com India
Natera president sells common stock worth $109,817 By Investing.com - Investing.com South Africa
Natera president sells common stock worth $109,817 - Investing.com
Natera CEO Leonard Chapman sells $468,113 in stock - Investing.com
Loss-Making Natera, Inc. (NASDAQ:NTRA) Expected To Breakeven In The Medium-Term - Yahoo Finance
Canaccord raises Natera stock target, keeps buy rating on growth potential - Investing.com Canada
Canaccord raises Natera stock target, keeps buy rating on growth potential By Investing.com - Investing.com South Africa
Why Is Natera Stock up 100% This Year? - Nanalyze
Natera (NASDAQ:NTRA) Price Target Raised to $150.00 at Canaccord Genuity Group - MarketBeat
Liquid Biopsy Market Set for Explosive Growth by 2024-2031: Key Trends and Drivers | MDxHealth SA, Natera, Inc - EIN News
Natera: A Genetic Investment Worth Watching And Holding - Seeking Alpha
Natera, Inc. (NASDAQ:NTRA) CFO Michael Burkes Brophy Sells 691 Shares - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Short Interest Update - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Mount Yale Investment Advisors LLC - MarketBeat
Natera CFO Michael Burkes sells shares worth $191,037 By Investing.com - Investing.com South Africa
Natera CFO Michael Burkes sells shares worth $191,037 - Investing.com India
HWG Holdings LP Buys 11,911 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera (NASDAQ:NTRA) Downgraded by StockNews.com to Sell - MarketBeat
All You Need to Know About Natera (NTRA) Rating Upgrade to Strong Buy - MSN
Solomon Moshkevich Sells 256 Shares of Natera, Inc. (NASDAQ:NTRA) Stock - MarketBeat
Natera CFO Michael Burkes sells shares worth $59,068 By Investing.com - Investing.com Australia
Natera's president sells shares worth $65,192 By Investing.com - Investing.com South Africa
Natera's president of clinical diagnostics sells $66,241 in shares By Investing.com - Investing.com South Africa
Natera's president of clinical diagnostics sells $66,241 in shares - Investing.com India
Natera CFO Michael Burkes sells shares worth $59,068 - Investing.com India
Natera's president sells shares worth $65,192 - Investing.com
Natera, Inc. (NASDAQ:NTRA) CFO Sells $73,422.08 in Stock - MarketBeat
Natera's chief legal officer sells $98,298 in stock By Investing.com - Investing.com South Africa
Natera's CFO Michael Burkes sells shares worth $127,932 - Investing.com India
Natera's chief legal officer sells $98,298 in stock - Investing.com India
Natera's CFO Michael Burkes sells shares worth $127,932 By Investing.com - Investing.com South Africa
Natera CEO Steven Chapman sells $313k in stock - Investing.com
Natera CEO Steven Chapman sells $313k in stock By Investing.com - Investing.com UK
Important Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Natera, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit - Marketscreener.com
Natera to Present New Renasight Data at ASN Kidney Week 2024 - StockTitan
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):